Android app on Google Play

Isis Pharmaceuticals, Inc. (ISIS) Higher After Tops Q2 EPS by 9c

August 6, 2012 12:56 PM EDT Send to a Friend
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) are trading higher after the company reported Q2 EPS of ($0.01), $0.09 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $47.3 million versus the consensus estimate of $40.06 million.

For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment